Literature DB >> 19994881

Theoretical and experimental studies of the isomeric protonation in solution for a prototype aliphatic ring containing two nitrogens.

Peter I Nagy1, Aditya Maheshwari, Yong-Wah Kim, William S Messer.   

Abstract

Theoretical calculations were carried out for studying the tautomeric protonation of N-methylpiperazine as a prototype six-member aliphatic ring containing a secondary and a tertiary nitrogen atom. The protonation was investigated in three solvents, water, acetonitrile, and dichloromethane. Calculations were performed up to the B3LYP/aug-cc-pvtz and QCISD(T)/CBS levels by applying the IEF-PCM polarizable continuum dielectric solvent model. Relative solvation free energies also were calculated upon explicit solvent models by utilizing the free-energy perturbation theory as implemented in Monte Carlo simulations. The relative free energy for the N-methylpiperazine tautomer protonated at the secondary (NMps) rather than at the tertiary (NMpt) nitrogen was calculated at a ratio of 47/53 in infinitely dilute aqueous solution. The ratio further decreased in lower-polarity solvents. In contrast, NMR experiments suggested that the protonation takes place primarily at the secondary nitrogen in 0.37 molar aqueous solution with NMps/NMpt = 80/20. The NMps tautomer was exclusive in dichloromethane at the same concentration. The discrepancy between theory and experiment was resolved by considering association equilibria in parallel with the protonation for the solute. As a result, the theoretically predicted tautomer ratios were obtained in close agreement with the experimental values. The NMps tautomer could form a preferable dimeric structure, where one or two chloride anion(s) was/were in hydrogen bonds with protons of the associating monomers. The calculations suggest that the proton relocation may take place by solvent assistance in water or along an intramolecular proton jump in the twist-boat conformation. The predicted activation free energy was about 10 kcal/mol on the basis of variable-temperature NMR experiments in DCM.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19994881      PMCID: PMC2827250          DOI: 10.1021/jp9082085

Source DB:  PubMed          Journal:  J Phys Chem B        ISSN: 1520-5207            Impact factor:   2.991


  25 in total

1.  First-principles calculation of pKa for cocaine, nicotine, neurotransmitters, and anilines in aqueous solution.

Authors:  Haiting Lu; Xi Chen; Chang-Guo Zhan
Journal:  J Phys Chem B       Date:  2007-08-11       Impact factor: 2.991

2.  Synthesis and biochemical activity of novel amidine derivatives as m1 muscarinic receptor agonists.

Authors:  B Ojo; P G Dunbar; G J Durant; P I Nagy; J J Huzl; S Periyasamy; D O Ngur; A A el-Assadi; W P Hoss; W S Messer
Journal:  Bioorg Med Chem       Date:  1996-10       Impact factor: 3.641

3.  Theoretical study of the enol imine <--> enaminone tautomeric equilibrium in organic solvents.

Authors:  Peter I Nagy; Walter M F Fabian
Journal:  J Phys Chem B       Date:  2006-12-14       Impact factor: 2.991

4.  Design, synthesis, and biological characterization of bivalent 1-methyl-1,2,5,6-tetrahydropyridyl-1,2,5-thiadiazole derivatives as selective muscarinic agonists.

Authors:  W G Rajeswaran; Y Cao; X P Huang; M E Wroblewski; T Colclough; S Lee; F Liu; P I Nagy; J Ellis; B A Levine; K H Nocka; W S Messer
Journal:  J Med Chem       Date:  2001-12-20       Impact factor: 7.446

5.  Theoretical studies of the tautomeric equilibria for five-member N-heterocycles in the gas phase and in solution.

Authors:  Peter I Nagy; Frederick R Tejada; William S Messer
Journal:  J Phys Chem B       Date:  2005-12-01       Impact factor: 2.991

6.  Synthesis and biological characterization of 1,4,5,6-tetrahydropyrimidine and 2-amino-3,4,5,6-tetrahydropyridine derivatives as selective m1 agonists.

Authors:  W S Messer; Y F Abuh; Y Liu; S Periyasamy; D O Ngur; M A Edgar; A A El-Assadi; S Sbeih; P G Dunbar; S Roknich; T Rho; Z Fang; B Ojo; H Zhang; J J Huzl; P I Nagy
Journal:  J Med Chem       Date:  1997-04-11       Impact factor: 7.446

7.  Theoretical conformational analysis for neurotransmitters in the gas phase and in aqueous solution. Norepinephrine.

Authors:  Peter I Nagy; Giuliano Alagona; Caterina Ghio; Krisztina Takács-Novák
Journal:  J Am Chem Soc       Date:  2003-03-05       Impact factor: 15.419

8.  Theoretical Conformational Analysis for Neurotransmitters in the Gas Phase and in Aqueous Solution. Serotonin.

Authors:  Giuliano Alagona; Caterina Ghio; Peter I Nagy
Journal:  J Chem Theory Comput       Date:  2005-09       Impact factor: 6.006

Review 9.  Predicting and tuning physicochemical properties in lead optimization: amine basicities.

Authors:  Martin Morgenthaler; Eliane Schweizer; Anja Hoffmann-Röder; Fausta Benini; Rainer E Martin; Georg Jaeschke; Björn Wagner; Holger Fischer; Stefanie Bendels; Daniel Zimmerli; Josef Schneider; François Diederich; Manfred Kansy; Klaus Müller
Journal:  ChemMedChem       Date:  2007-08       Impact factor: 3.466

10.  Theoretical Investigation of Tautomeric Equilibria for Isonicotinic Acid, 4-Pyridone, and Acetylacetone in Vacuo and in Solution.

Authors:  Peter I Nagy; Giuliano Alagona; Caterina Ghio
Journal:  J Chem Theory Comput       Date:  2007-07       Impact factor: 6.006

View more
  3 in total

Review 1.  Competing intramolecular vs. intermolecular hydrogen bonds in solution.

Authors:  Peter I Nagy
Journal:  Int J Mol Sci       Date:  2014-10-28       Impact factor: 5.923

2.  Theoretical studies of the in-solution isomeric protonation of non-aromatic six-member rings with two nitrogens.

Authors:  Peter I Nagy; William S Messer
Journal:  J Phys Chem B       Date:  2011-03-31       Impact factor: 2.991

Review 3.  Multidimensional insights into the repeated electromagnetic field stimulation and biosystems interaction in aging and age-related diseases.

Authors:  Felipe P Perez; Joseph P Bandeira; Cristina N Perez Chumbiauca; Debomoy K Lahiri; Jorge Morisaki; Maher Rizkalla
Journal:  J Biomed Sci       Date:  2022-06-13       Impact factor: 12.771

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.